Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Flux Biosciences was a private healthcare diagnostics company spun out of Stanford University that developed magnetic sensing technology for quantitative point-of-care and at-home in vitro diagnostics. The company aimed to measure biomarkers from blood, urine, and saliva and integrate those results with wearable-derived activity and sleep data to deliver consumer health insights. Its technology originated from magnetic nanotechnology and hard-drive sensing approaches adapted for medical diagnostics. Flux Biosciences appears to have focused on home and decentralized testing rather than therapeutics, and public sources indicate the company later became inactive or closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Flux Biosciences.